Structural Basis for Inhibition of the AAA-ATPase Drg1 by Diazaborine
Overview
Authors
Affiliations
The hexameric AAA-ATPase Drg1 is a key factor in eukaryotic ribosome biogenesis and initiates cytoplasmic maturation of the large ribosomal subunit by releasing the shuttling maturation factor Rlp24. Drg1 monomers contain two AAA-domains (D1 and D2) that act in a concerted manner. Rlp24 release is inhibited by the drug diazaborine which blocks ATP hydrolysis in D2. The mode of inhibition was unknown. Here we show the first cryo-EM structure of Drg1 revealing the inhibitory mechanism. Diazaborine forms a covalent bond to the 2'-OH of the nucleotide in D2, explaining its specificity for this site. As a consequence, the D2 domain is locked in a rigid, inactive state, stalling the whole Drg1 hexamer. Resistance mechanisms identified include abolished drug binding and altered positioning of the nucleotide. Our results suggest nucleotide-modifying compounds as potential novel inhibitors for AAA-ATPases.
The novel ribosome biogenesis inhibitor usnic acid blocks nucleolar pre-60S maturation.
Kofler L, Grundmann L, Gerhalter M, Prattes M, Merl-Pham J, Zisser G Nat Commun. 2024; 15(1):7511.
PMID: 39209816 PMC: 11362459. DOI: 10.1038/s41467-024-51754-3.
Suresh H, Bonneil E, Albert B, Dominique C, Costanzo M, Pons C Mol Cell. 2024; 84(12):2337-2352.e9.
PMID: 38870935 PMC: 11193623. DOI: 10.1016/j.molcel.2024.05.018.
Ribosome biogenesis and function in development and disease.
Ni C, Buszczak M Development. 2023; 150(5).
PMID: 36897354 PMC: 10108708. DOI: 10.1242/dev.201187.
Raggio V, Grana M, Winiarski E, Mansilla S, Simoes C, Rodriguez S Hum Genomics. 2023; 17(1):14.
PMID: 36849973 PMC: 9972848. DOI: 10.1186/s40246-023-00463-x.
Fu J, Zhang J, Chen X, Liu Z, Yang X, He Z Theranostics. 2023; 13(2):787-809.
PMID: 36632213 PMC: 9830439. DOI: 10.7150/thno.78840.